DrugPatentWatch Database Preview
CLINDESSE Drug Profile
Which patents cover Clindesse, and when can generic versions of Clindesse launch?
Clindesse is a drug marketed by Perrigo Pharma Intl and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has forty-four patent family members in twenty-one countries.
The generic ingredient in CLINDESSE is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Summary for CLINDESSE
International Patents: | 44 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 2 |
Bulk Api Vendors: | 37 |
Clinical Trials: | 1 |
Patent Applications: | 1,173 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CLINDESSE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CLINDESSE |
DailyMed Link: | CLINDESSE at DailyMed |

Pharmacology for CLINDESSE
Drug Class | Lincosamide Antibacterial |
Physiological Effect | Decreased Sebaceous Gland Activity |
US Patents and Regulatory Information for CLINDESSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perrigo Pharma Intl | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
Perrigo Pharma Intl | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for CLINDESSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Perrigo Pharma Intl | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | ➤ Sign Up | ➤ Sign Up |
Perrigo Pharma Intl | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | ➤ Sign Up | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for CLINDESSE
Drugname | Dosage | Strength | RLD | Date |
---|---|---|---|---|
➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | ➤ Sign Up |
International Patents for CLINDESSE
Country | Document Number | Estimated Expiration |
---|---|---|
Argentina | 047108 | ➤ Sign Up |
Eurasian Patent Organization | 200870154 | ➤ Sign Up |
World Intellectual Property Organization (WIPO) | 2007079390 | ➤ Sign Up |
Canada | 2635992 | ➤ Sign Up |
Japan | 2007505927 | ➤ Sign Up |
Israel | 192565 | ➤ Sign Up |
Malaysia | 144021 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for CLINDESSE
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
13/044 | Ireland | ➤ Sign Up | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
2013 00053 | Denmark | ➤ Sign Up | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
00617 | Netherlands | ➤ Sign Up | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
2013025,C1304992 | Lithuania | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
1304992/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
401 | Luxembourg | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |